Your browser doesn't support javascript.
loading
Experience of indinavir/ritonavir 400/100 mg twice-daily highly active antiretroviral therapy-containing regimen in HIV-1-infected patients in Bamako, Mali: the NOGOMA Study.
J Acquir Immune Defic Syndr ; 45(4): 477-9, 2007 Aug 01.
Article in En | MEDLINE | ID: mdl-17622837
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease Inhibitors / Indinavir / Ritonavir / Antiretroviral Therapy, Highly Active Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2007 Document type: Article Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease Inhibitors / Indinavir / Ritonavir / Antiretroviral Therapy, Highly Active Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2007 Document type: Article Country of publication: United States